Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Drug Discovery Screening 100 Times Faster
Scientific Advances

Drug Discovery Screening 100 Times Faster

By Nora DunneAug 25, 2014
Share
Facebook Twitter Email
SAMDI’s robotic arms deposit proteins to tiny gold-surfaced circles on a metal plate. 

 

 

Milan Mrksich, PhD, professor in Cell and Molecular Biology, has created a tool and a startup company to measure enzyme reactions 100 times faster than a big pharmaceutical company can, let alone a few scientists in a lab.

The tool is called SAMDI, which stands for self-assembled monolayers desorption ionization. It can assess the biochemical activities of 100,000 compounds a day to see how thousands of proteins interact to make a cell function. With SAMDI, scientists can screen enzyme interactions to develop drugs. They can study how proteins function in organs to pinpoint disease risk. In a nutshell, the tool makes it possible to test unlimited biological reactions quickly and cheaply.

Mrksich is a biomedical engineer, chemical biologist and expert in nanotechnology and materials science. He’s also an entrepreneur with three startups on his résumé, the latest a technology company that runs tests using the SAMDI platform.

“The goal is to have SAMDI Tech serve the drug development industry by performing assay services and high throughput screening. In my own lab, we are using the SAMDI technology to get fundamental insights into the ways that normal and diseased cells differ,” said Mrksich, who holds joint appointments at Northwestern University’s Feinberg School of Medicine, McCormick School of Engineering and Weinberg College of Arts and Sciences.

Mrksich formed SAMDI Tech in 2011, the same year he joined Northwestern after 15 years at the University of Chicago. He earned his PhD in organic chemistry from the California Institute of Technology.

One of the ways Milan Mrksich, PhD, and his lab use SAMDI is to understand the ways normal and diseased cells differ.

SAMDI is “label-free,” meaning compounds don’t need chemical additives like antibodies, fluorescent labels or radioactivity to mark a specific protein reaction. A robotic arm deposits proteins to tiny gold-surfaced circles on a metal plate and drops in a solution of interest. Afterward, a laser beam releases the molecules from the base and exposes the chemical reaction that occurred.

“We are now able to grow a cell culture, generate a lysate from those cultures and test the lysate for a broad range of enzyme activities. By comparing the patterns of activities in normal and diseased cells, we get clues as to what may drive disease and, in turn, what targets may be suitable for developing drugs against the disease,” said Mrksich, a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Mrksich spends about a third of his time on the Chicago campus, much of it collaborating with other Feinberg scientists.

“By having a lab downtown, my group can take our recent tools and apply them to exciting medical problems,” said Mrksich. “These are problems where an advance can translate into a huge impact for a patient population.”

Pharmacology Research
Share. Facebook Twitter Email

Related Posts

Genetic Variations Influence Drug Metabolism in Patients of African Descent

Feb 7, 2023

Potential Therapeutic Target for Schizophrenia Identified 

Feb 6, 2023

Longtime Alcohol Consumption Speeds Up Biological Aging 

Feb 3, 2023

Comments are closed.

Latest News

Workshop Teaches Medical Students Diagnosis Skills in Dermatology

Feb 7, 2023

Genetic Variations Influence Drug Metabolism in Patients of African Descent

Feb 7, 2023

Potential Therapeutic Target for Schizophrenia Identified 

Feb 6, 2023

Longtime Alcohol Consumption Speeds Up Biological Aging 

Feb 3, 2023

Grant Provides Imaging Technology to Department of Ophthalmology

Feb 2, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
Feinberg_In_Vivo_20221209_tcrawford-24
Feinberg_In_Vivo_20221209_tcrawford-16
Feinberg_In_Vivo_20221209_tcrawford-14
Feinberg_In_Vivo_20221209_tcrawford-5
Feinberg_In_Vivo_20221209_tcrawford-6
Feinberg_In_Vivo_20221209_tcrawford-10
Feinberg_In_Vivo_20221209_tcrawford-8
Feinberg_In_Vivo_20221209_tcrawford-18
Feinberg_In_Vivo_20221209_tcrawford
Feinberg_In_Vivo_20221209_tcrawford-23
Feinberg_In_Vivo_20221209_tcrawford-25
Feinberg_In_Vivo_20221209_tcrawford-26

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.